Clinicopathologic characters of central nervous system primary melanocytic tumors

doi:10.3969/j.issn.1672-6731.2021.08.010

Abstract

Abstract:

Objective To investigate the central nervous system (CNS) primary melanocytic tumors (melanocytic tumors) and improve the understanding of melanocytic tumors. Methods and Results Since January 2012 to October 2019, 7 cases of melanocytic tumors were collected in Guangdong 999 Brain Hospital. Five patients underwent surgical resection and 2 patients underwent tissue biopsy. MRI showed high signal in T₁WI, low signal in T₂WI, and high signal in FLAIR. Tumor cell assumed a variety of shapes, including oval and polygonal, melanin-containing macrophages from benign to atypical. Results of immunohistochemistry showed that Melan-A and S-100 protion were consistently positive, and HMB-45 was negative, scattered or strongly positive. Four patients were diagnosed with meningeal melanocytoma, one with meningeal melanoma, one with diffuse meningeal melanocytosis, and one with meningeal melanomatosis. Four cases of melanocytoma underwent total or major resection, and of 3 cases received postoperative radiotherapy. The 2 cases who received radiotherapy were in good condition after follow-up of 56 and 116 months. The one case did not receive radiotherapy stay alive for 20 months. One meningeal melanomatosis patient received postoperative chemoradiotherapy, with a total survival time of 15 months. One patient with diffuse melanocytosis had a total survival time of 13 months. One meningeal melanocytosis patient improved after 7 months received chemoradiotherapy. Conclusions CNS primary melanocytic tumors are rare. Meningeal melanocytoma is common in the elderly, while diffuse meningeal melanocytosis is common in children. The expression patterns of melanin markers Melan-A, S-100 are consistently expressed, and HMB-45 which helps to identify the benign and malignant tumors. The prognosis of tumour is still unclear. Melanocytoma has the best prognosis and benefits from radiotherapy.

Key words: Melanoma, Central nervous system neoplasms, Immunohistochemistry, Pathology

摘要：

目的总结中枢神经系统原发性黑色素细胞肿瘤（简称黑色素细胞肿瘤）的临床、影像学和病理学特征，提高对疾病的诊断与鉴别诊断能力。方法与结果 纳入2012年1月至2019年10月在广东三九脑科医院诊断与治疗的7例黑色素细胞肿瘤患者，5例手术切除，2例行组织活检术；MRI表现为T₁WI高信号，T₂WI低信号，FLAIR成像高信号；组织学形态由卵圆形或多边形黑色素细胞构成，胞核偏位，核仁嗜酸性，胞质内含数量不等的色素细胞，细胞异型性不等；免疫组化染色，Melan-A、S-100蛋白呈阳性，HMB-45呈阴性、散在阳性或强阳性。最终诊断为黑色素细胞瘤4例，黑色素瘤1例，弥漫性黑色素细胞增生症1例，黑色素瘤病1例。3例黑色素细胞瘤术后辅以放疗，其中2例分别随访56和116个月状态良好，1例失访；1例未行放疗的黑色素细胞瘤患者总生存期为20个月；1例黑色素瘤患者术后辅以放化疗，总生存期为15个月；1例弥漫性黑色素细胞增生症患者总生存期为13个月；1例黑色素瘤病患者经放化疗后7个月状态良好。结论中枢神经系统原发性黑色素细胞肿瘤罕见，黑色素细胞瘤常见于中老年人，黑色素细胞增生症好发于儿童。肿瘤细胞恒定表达Melan-A和S-100蛋白，而HMB-45表达模式有助于鉴别肿瘤良恶性。肿瘤预后尚不清楚，黑色素细胞瘤预后最好，放疗可获益。

关键词: 黑色素瘤, 中枢神经系统肿瘤, 免疫组织化学, 病理学

CHENG Bai-jie, LI Hai-nan, DENG Da-biao, XU Shao-qiang, LI Zhi. Clinicopathologic characters of central nervous system primary melanocytic tumors[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2021, 21(8): 670-678.

成白洁, 李海南, 邓达标, 许少强, 李智. 中枢神经系统原发性黑色素细胞肿瘤临床病理学特征[J]. 中国现代神经疾病杂志, 2021, 21(8): 670-678.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2021.08.010

https://journal11.magtechjournal.com/cjcnn/EN/Y2021/V21/I8/670

References

[1] Kleihues P, Cavenee WK (eds). Pathology and Genetics of Tumours of the Nervous System:World Health Organization Classification of Tumours[M]//Jellinger KA, Chou P, Paulus W. Melanocytic lesions. Lyon:International Agency for Research on Cancer, 2000:193-195.
[2] Smith AB, Rushing EJ, Smirniotopoulos JG. Pigmented lesions of the central nervous system:radiologic-pathologic correlation[J]. Radiographics, 2009, 29:1503-1524.
[3] Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of the tumours of the central nervous system[M]//Brat DJ, Perry A, Wesselin P, Bastian BC. Menlanocytic tumours. Lyon:International Agency for Research on Cancer, 2016:266-270.
[4] Eun SS, Kim HS, Lee SH, Liu WC, Lee JH. Spinal meningeal melanocytoma in the S-1 nerve root sheath with paraspinal extension mimicking schwannoma[J]. World Neurosurg, 2011, 75:303-306.
[5] Muthappan M, Muthu T, Hussain Z, Lamont D, Balakrishnan V. Cervical intramedullary melanocytoma:a case report and review of literature[J]. J Clin Neurosci, 2012, 19:1450-1453.
[6] Zhao Y, Li NY, Zhou XJ, Chen ZH, Wu B, Ma HH. Clinical and pathological analysis of meningeal melanocytoma[J]. Lin Chuang Yu Shi Yan Bing Li Xue Za Zhi, 2002, 18:46-49. [赵燕, 李南云, 周晓军, 陈忠豪, 吴波, 马恒辉. 脑脊膜黑色素细胞瘤的临床病理分析[J]. 临床与实验病理学杂志, 2002, 18:46-49.]
[7] Demirci A, Kawamura Y, Sze G, Duncan C. MR of parenchymal neurocutaneous melanosis[J]. AJNR Am J Neuroradiol, 1995, 16:603-606.
[8] Küsters-Vandevelde HV, Küsters B, van Engen-van Grunsven AC, Groenen PJ, Wesseling P, Blokx WA. Primary melanocytic tumours of the central nervous system:a review with focus on molecular aspects[J]. Brain Pathol, 2015, 25:209-226.
[9] Choi DK, Pillay-Smiley N, Marzec S, Wadhwani NR, DiPatri AJ, Tomita T, Lulla RR. Primary central nervous system malignant melanoma in children:a case series and review of the literature[J]. J Pediatr Hematol Oncol, 2018, 40:616-619.
[10] Brat DJ, Giannini C, Scheithauer BW, Burger PC. Primary melanocytic neoplasms of the central nervous system[J]. Am J Surg Pathol, 1999, 23:745-754.
[11] Alwatban J, Tampieri D, Salazar A, Melançon D, Duong H. MRI of leptomeningeal melanocytosis in a patient with neurofibromatosis[J]. J Comput Assist Tomogr, 1997, 21:38-40.
[12] Poe LB, Roitberg D, Galyon DD. Neurocutaneous melanosis presenting as an intradural mass of the cervical canal:magnetic resonance features and the presence of melanin as a clue to diagnosis:case report[J]. Neurosurgery, 1994, 35:741-743.
[13] Doglietto F, Colosimo C, Lauriola L, Balducci M, De Bonis P, Montano N, Zadeh G, Maira G, Pallini R. Intracranial melanocytic meningeal tumours and melanosis oculi:case report and literature review[J]. BMC Cancer, 2012, 12:220.
[14] Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of the tumours of the central nervous system[M]//Reifenberger G, Rodriguez F, Burger PC, Perry A, Capper D. Diffuse leptomeningeal glioneuronal tumour. Lyon:IARC, 2016:152-155.
[15] Prabhu SS, Lynch PG, Keogh AJ, Parekh HC. Intracranial meningeal melanocytoma:a report of two cases and a review of the literature[J]. Surg Neurol, 1993, 40:516-521.
[16] Ritter A, Tronnier M, Vaske B, Mitteldorf C. Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma[J]. Arch Dermatol Res, 2018, 310:329-342.
[17] Uguen A, Uguen M, Guibourg B, Talagas M, Marcorelles P, De Braekeleer M. The p16-ki-67-HMB45 immunohistochemistry scoring system is highly concordant with the fluorescent in situ hybridization test to differentiate between melanocytic nevi and melanomas[J]. Appl Immunohistochem Mol Morphol, 2018, 26:361-367.
[18] Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer[J]. Nature, 2002, 417:949-954.
[19] Greaves WO, Verma S, Patel KP, Davies MA, Barkoh BA, Galbincea JM, Yao H, Lazar AJ, Aldape KD, Medeiros LJ, Luthra R. Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma[J]. J Mol Diagn, 2013, 15:220-226.
[20] Greco Crasto S, Soffietti R, Bradac GB, Boldorini R. Primitive cerebral melanoma:case report and review of the literature[J]. Surg Neurol, 2001, 55:163-168.
[21] Kadonaga JN, Frieden IJ. Neurocutaneous melanosis:definition and review of the literature[J]. J Am Acad Dermatol, 1991, 24(5 Pt 1):747-755.
[22] Miró J, Velasco R, Majós C, Gil M, Boluda S, Bruna J. Meningeal melanocytosis:a possibly useful treatment for a rare primary brain neoplasm[J]. J Neurol, 2011, 258:1169-1171.
[23] Rodriguez y Baena R, Gaetani P, Danova M, Bosi F, Zappoli F. Primary solitary intracranial melanoma:case report and review of the literature[J]. Surg Neurol, 1992, 38:26-37.
[24] Subbiah V, Wolff JE. Rapid response to therapy of neurocutaneous melanosis with leptomeningeal melanoma[J]. Pediatr Blood Cancer, 2010, 54:180-181.

Please choose a citation manager

Content to export